• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET Back to Search Results
Catalog Number 10310
Device Problems Use of Device Problem (1670); Insufficient Information (3190); Device Handling Problem (3265)
Patient Problem Hypervolemia (2664)
Event Date 10/04/2023
Event Type  malfunction  
Manufacturer Narrative
Lot number and expiry information are not available at this time.Investigation: calculate final fluid balance (including saline bolus): 123%.Patient final fluid balance displayed by the system: 116%.The customer reported that they have initiated an internal capa to evaluate the event.Investigation is in process, a follow-up report will be provided.
 
Event Description
The customer reported to terumo bct customer support that during a continuous mononuclear cell collection (cmnc) procedure they were having problems stabilizing the interface.The customer lowered the hct and ac ratio and then noticed that the red saline roller clamp was open and the normal saline bag was empty.She replaced the bag, but was still unable to establish the interface.The customer reported that the hct was 38 and the interface was at 1/4, so customer support suggested she lower the hct to 32 and after a few minutes the interface was in the correct position.There were cells in the collect port so customer support provided instructions on how to continue with the run by adjusting the cp and opening the collect valve when they reached the desired color.Donor voiced not complaints, exhibited no adverse reactions.Donor remained baseline throughout the procedure.The collection set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
Investigation: calculate final fluid balance (including saline bolus): 123%.Patient final fluid balance displayed by the system: 116%.The customer reported that they have initiated an internal capa to evaluate the event.A disposable lot history search indicated there were no other reported occurrences of open inlet saline roller clamp on this lot worldwide.A review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.Correction: terumo bct clinical specialist reminded the customer to check and make sure that the saline roller clamps were closed.The customer verified and acknowledged that the inlet saline roller clamp was inadvertently left open.In a subsequent follow-up, the customer declined the offer of retraining.Root cause: a root cause assessment was performed for the unintended saline bolus to the donor.Based on the customer's statements, she failed to follow the screen prompt to fully close the inlet saline roller clamp at the end of prime divert.
 
Event Description
The customer reported to terumo bct customer support that during a continuous mononuclear cell collection (cmnc) procedure they were having problems stabilizing the interface.The customer lowered the hct and ac ratio and then noticed that the red saline roller clamp was open and the normal saline bag was empty.She replaced the bag, but was still unable to establish the interface.The customer reported that the hct was 38 and the interface was at 1/4, so customer support suggested she lower the hct to 32 and after a few minutes the interface was in the correct position.There were cells in the collect port so customer support provided instructions on how to continue with the run by adjusting the cp and opening the collect valve when they reached the desired color.Donor voiced not complaints, exhibited no adverse reactions.Donor remained baseline throughout the procedure.The collection set is not available for return because it was discarded by the customer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA IDL SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer (Section G)
TERUMO BCT
10810 w. collins ave
lakewood CO 80215
Manufacturer Contact
scot hilden
10810 w. collins ave
lakewood, CO 80215
MDR Report Key18013220
MDR Text Key326935940
Report Number1722028-2023-00354
Device Sequence Number1
Product Code LKN
UDI-Device Identifier05020583103108
UDI-Public05020583103108
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K183081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 10/26/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number10310
Device Lot Number2305096141
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/04/2023
Initial Date FDA Received10/26/2023
Supplement Dates Manufacturer Received11/17/2023
Supplement Dates FDA Received11/20/2023
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age26 YR
Patient SexFemale
-
-